Compare PETS & GSIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PETS | GSIW |
|---|---|---|
| Founded | 1996 | 2016 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Retail-Drug Stores and Proprietary Stores | |
| Sector | Consumer Staples | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.8M | 33.9M |
| IPO Year | N/A | 2023 |
| Metric | PETS | GSIW |
|---|---|---|
| Price | $1.65 | $0.15 |
| Analyst Decision | Sell | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $3.20 | N/A |
| AVG Volume (30 Days) | 225.0K | ★ 462.3K |
| Earning Date | 02-02-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $226,972,000.00 | $5,368,221.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.98 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 283.23 |
| 52 Week Low | $1.59 | $0.09 |
| 52 Week High | $6.85 | $1.79 |
| Indicator | PETS | GSIW |
|---|---|---|
| Relative Strength Index (RSI) | 32.70 | 49.05 |
| Support Level | $1.69 | $0.14 |
| Resistance Level | $1.83 | $0.16 |
| Average True Range (ATR) | 0.12 | 0.01 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 13.04 | 45.63 |
PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.
Garden Stage Ltd is a Hong Kong-based financial services provider principally engaged in the provision of placing and underwriting services; securities dealing and brokerage services; and asset management services. Its business is carried out through its wholly owned Operating Subsidiaries: I Win Securities, which is licensed to conduct Type 1 (dealing in securities) regulated activities under the SFO in Hong Kong; and I Win Asset Management, which is licensed to conduct Type 4 (advising on securities) and Type 9 (asset management) regulated activities under the SFO in Hong Kong.